Clarke Cole

Global health researcher. Following pharma R&D, access to medicines, global health.

[Clarke Cole @clarkebcole]

Pleased to share the latest commentary on measuring and incentivising #pharma contributions to #health R&D @StineTrolle @dannyjedwards @AtMIndex https://t.co/ORqxhKS59J

[Global Strategy Lab @gstrategylab]

Presented at today’s #GSLLunchAndLearn, research done by @clarkebcole and @shoffmania on mapping global health actors:
https://t.co/JTM8RMOZVi

[Access to Medicine Foundation @AtMIndex]

How can companies accelerate R&D of #meds & #vaccines for #LMICs? We have worked with @BIOVentures to develop a framework that can guide #pharma co.s in making decisions about sharing their #intellectualproperty with #globalhealth researchers: https://t.co/jdCD733TEk

[Access to Medicine Foundation @AtMIndex]

.@BillGates at #WEF18: When the Access to Medicine Index came along, pharma companies could get credit for actually working on infectious diseases.

https://t.co/WDqnj74C0d

#ATMIndex2018 #AMRBenchmark @JayasreeKIyer @joelletanguy @BeckyQuick @gatesfoundation @minvws @DFID_UK

[Access to Medicine Foundation @AtMIndex]

Starting at 1pm: how new leadership, policy and business models are rewriting the global health playbook. With @JayasreeKIyer, @BillGates and others at @WEF #WEF2018 https://t.co/nA3abOoQab

@BillGates @gatesfoundation @trevormundel @DutchMFA @markrutte @MarcelvanRaaij
@DFID_UK

[Access to Medicine Foundation @AtMIndex]

To tackle #superbugs, we need new #meds to be developed, and new ideas to make sure #antimicrobials are available but being used wisely.The #AMRBenchmark has identified priorities for #pharma co.s in tackling #AMR: https://t.co/BmdMMKZYkw

[Access to Medicine Foundation @AtMIndex]

Two hours to go: watch the press conference about the first #AMRBenchmark at the @WEF – it starts at 1pm GMT/ 2pm CET/ 8am EST/ 6:30pm IST/10pm JST. Find out which #pharma companies do more to curb #AMR https://t.co/M8nhL930ja

[Clarke Cole @clarkebcole]

Pleased to be part of the discussion on access to #vaccines at the Utrecht-WHO Winter Meeting today. #ATVI2017 @AtMIndex

[Access to Medicine Foundation @AtMIndex]

4 best practices. 4 supporting actions. 1 goal - improving access to #ARVs through #licensing. Our @clarkebcole, @dannyjedwards & @CHAI_Health explain what best practice looks like for ARV licensing: https://t.co/R3MJZrWUxh #WorldAIDSDay2017

[Nachtsnuiver @nachtsnuiver]

Tomorrow @maunomusicband will be playing @SugarfactoryNL. @clarkebcole wrote a preview for #Nachtsnuiver https://t.co/xK8k4Jq1EB #blog

[Access to Medicine Foundation @AtMIndex]

Today – great discussions with our Expert Committee about the methodology for the next Access to Medicine Index.

[Access to Medicine Foundation @AtMIndex]

Which new #vaccines are in the pipeline? 2017 Access to Vaccines Index finds 89 vaccine #R&D projects https://t.co/rMXZZxUaQg

[Clarke Cole @clarkebcole]

Thanks @Intravacc for a great discussion today about the #atvi2017. Good to explore how our new research can be put to use. @AtMIndex

[Jayasree Iyer @JayasreeKIyer]

access2vaccines Index #ATVI2017 @clarkebcole presenting results of #R&D & importance of partnerships @Intravacc @AtMIndex @ChrRebergen

[Access to Medicine Foundation @AtMIndex]

Online now: 2017 Access to Vaccines Index! #ATVI2017
https://t.co/JDvsLAq30r

[Clarke Cole @clarkebcole]

Discussing collaborative R&D of #vaccines for emerging infections at CEPI Scientific Community Meeting @CEPIvaccines @ATMI #ATVI2017

[Luca Genovese @lucagenoves]

Getting ready for seminar on pharma compliance and @AtMIndex at @Uoft

[Damiano de Felice @damidefelice]

Tomorrow @clarkebcole will present 2016 @AtMIndex to @ISGLOBALorg students and staff. Looking forward to the discussion! #access2meds

[Suzanne Wolf @SuzanneWolfATMI]

#ATMI2016 @TaraLPrasad @JayasreeKIyer discussing affordability strategies of #pharma co's in poor countries @GoldmanSachs investor briefing

[Suzanne Wolf @SuzanneWolfATMI]

#ATMI2016 Briefing started @GoldmanSachs, @JayasreeKIyer and Keyur Parekh introducing #access2meds & change investors & #pharma van make.